Difelikefalin (INN; developmental code name ADM-5885) is an investigational drug candidate being developed by Arena Pharmaceuticals as a potential treatment for obesity. It is a selective agonist of the niacin receptor GPR109A, also known as HM74A, which is expressed primarily in adipose tissue and is believed to regulate lipid metabolism. In preclinical studies, difelikefalin was shown to reduce body weight and improve metabolic parameters, including lipid levels and glucose tolerance. The U.S. Food and Drug Administration (FDA) has granted difelikefalin orphan drug status for the treatment of obesity. Clinical trials of difelikefalin are currently ongoing.
Difelikefalin, sold under the brand name Korsuva, is a medication used to treat a specific type of itching. Here's a breakdown of its key aspects:
What it's for:
- Difelikefalin is used to treat moderate to severe itching associated with chronic kidney disease (CKD) in adults undergoing hemodialysis (a type of dialysis treatment for kidney failure). This itching is also known as uremic pruritus.
How it works:
- Difelikefalin belongs to a class of medications called kappa-opioid receptor agonists. It works by targeting specific receptors (kappa-opioid receptors) located on nerve cells and immune system cells. This helps to reduce itch signals sent to the brain.
Important points:
- Difelikefalin is administered intravenously (through a vein) at the end of each hemodialysis session.
- It's a relatively new medication, approved by the US Food and Drug Administration (FDA) in 2021.
- Difelikefalin works specifically in a way that avoids the central nervous system, unlike some other medications used for itching, which can cause drowsiness or other side effects.
Benefits:
- Studies have shown difelikefalin to be effective in reducing itch intensity compared to placebo in patients with chronic kidney disease undergoing hemodialysis.
Potential side effects:
- While generally well-tolerated, some common side effects of difelikefalin can include headache, dizziness, nausea, vomiting, and low blood pressure.
- Difelikefalin is not recommended for people with certain medical conditions or who are taking specific medications.
Getting Difelikefalin:
- Difelikefalin is a prescription medication only available under the supervision of a doctor.
- If you experience chronic itching associated with chronic kidney disease, consult your doctor to see if difelikefalin may be a suitable treatment option for you.
Additional resources:
- You can find more detailed information on Difelikefalin from the National Institutes of Health (NIH): https://pubmed.ncbi.nlm.nih.gov/35942600/ or [invalid URL difelikefalin medscape ON medscape.com].
- Remember, this information is for educational purposes only. Consult a healthcare professional for diagnosis and treatment of chronic itching or any other medical condition.